Elke Wühl, Otto Mehls, Franz Schaefer Kidney International

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and.

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Volume 54, Issue 2, Pages (August 1998)

Beta blockers in the management of chronic kidney disease

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Reassessment of the care of the patient with chronic kidney disease

Progression of renal failure and hypertensive nephrosclerosis

Section 5: Dialysis Interventions for Treatment of AKI

Burden of chronic kidney disease: North Africa

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Jeffrey C. Fink, Glenn M. Chertow Kidney International

C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go

Comorbidity and confounding in end-stage renal disease

Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load

Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Gautam R. Shroff, Charles A. Herzog

Volume 74, Issue 3, Pages (August 2008)

Lipid redistribution in renal dysfunction

N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment Martina Franz, Wolfgang Woloszczuk, Walter.

Volume 70, Issue 11, Pages (December 2006)

The epidemiology of chronic kidney disease

Volume 87, Issue 2, Pages (February 2015)

H. Wong, K. Mylrea, J. Feber, A. Drukker, G. Filler

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Ferruh Artunc, Friedhelm Hildebrandt, Kerstin Amann

Volume 59, Issue 4, Pages (April 2001)

Fructose intake as a risk factor for kidney stone disease

Volume 72, Issue 12, Pages (December 2007)

Volume 73, Issue 12, Pages (June 2008)

Volume 76, Issue 6, Pages (September 2009)

Alfonso M. Cueto-Manzano, Héctor R

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Elevated risk of stroke among patients with end-stage renal disease

Nephrology in Latin America, with special emphasis on Brazil

Methods for guideline development

Cardiovascular disease in pediatric chronic dialysis patients

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

Quiz Page August 2007 American Journal of Kidney Diseases

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita Kidney International

Volume 54, Issue 2, Pages (August 1998)

Volume 63, Issue 2, Pages (February 2003)

Opportunities for a chronic disease outreach program in China

Wei-Teing Chen, Horng-Chin Yan, Fu-Chiu Yu Kidney International

Volume 72, Issue 2, Pages (July 2007)

Volume 55, Pages S3-S16 (June 1999)

The Danish Renal Biopsy Register

Volume 80, Issue 10, Pages (November 2011)

Treatment of the primary hyperoxalurias: A new chapter

Is complement a target for therapy in renal disease?

Volume 70, Issue 3, Pages (August 2006)

Stephen G. Rostand, Tilman B. Drüeke Kidney International

Volume 70, Issue 5, Pages (September 2006)

Mild renal insufficiency is associated with reduced coronary flow in patients with non- obstructive coronary artery disease A.R. Chade, D. Brosh, S.T.

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

D.J. Askenazi, D.I. Feig, N.M. Graham, S. Hui-Stickle, S.L. Goldstein

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Antihypertensive and antiproteinuric efficacy of ramiprilin children with chronic renal failure Elke Wühl, Otto Mehls, Franz Schaefer Kidney International Volume 66, Issue 2, Pages 768-776 (August 2004) DOI: 10.1111/j.1523-1755.2004.00802.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Study flow chart. AHT, antihypertensive treatment; pts, patients. Kidney International 2004 66, 768-776DOI: (10.1111/j.1523-1755.2004.00802.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Change of 24-hour MAP SDS according to underlying renal disease. Bars represent mean ± SEM. Kidney International 2004 66, 768-776DOI: (10.1111/j.1523-1755.2004.00802.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Correlation between baseline 24-hour MAP and change of 24-hour MAP during ramipril treatment. Kidney International 2004 66, 768-776DOI: (10.1111/j.1523-1755.2004.00802.x) Copyright © 2004 International Society of Nephrology Terms and Conditions